IRON News and Press, Disc Medicine Inc. From 01/15/26

2026-01-15 07:10:00 ET More on Disc Medicine, Sanofi, etc. Disc Medicine, Inc. (IRON) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Disc Medicine, Inc. (IRON) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Sanofi (SAN:CA)...

2026-01-14 23:55:58 ET Disc Medicine, Inc. (IRON) 44th Annual J.P. Morgan Healthcare Conference January 14, 2026 6:00 PM EST... Read the full article on Seeking Alpha For further details see: Disc Medicine, Inc. (IRON) Presents at 44th Annual J.P. Morgan Healthcare Conferenc...

WATERTOWN, Mass., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the appointm...

Bitopertin was awarded the Commissioner’s National Priority Review Voucher (CNPV) and NDA is currently under FDA review Updated data from the Phase 2 study of DISC-0974 in patients with myelofibrosis (MF) and anemia expected in H2 2026, followed by an End of Phase 2 Meeting Initial data ...

WATERTOWN, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that John Qu...

2026-01-05 05:37:38 ET ... Read the full article on Seeking Alpha For further details see: Disc Medicine: RALLY-MF Data Validates Pipeline Optionality

2025-12-07 14:33:12 ET Disc Medicine, Inc. (IRON) Discusses ASH Conference Data Updates and Portfolio Progress Including Anemia and Iron Restriction Programs December 7, 2025 7:30 AM EST... Read the full article on Seeking Alpha For further details see: Disc Medicine, Inc. (...

Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response was seen independent of concomitant JAK inhibitor therapy use WATERTOWN, Mass., Dec. 06, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IR...

2025-11-19 12:13:24 ET Disc Medicine, Inc. (IRON) Jefferies London Healthcare Conference 2025 November 19, 2025 9:00 AM EST... Read the full article on Seeking Alpha For further details see: Disc Medicine, Inc. (IRON) Presents at Jefferies London Healthcare Conference 2025 T...

2025-11-18 17:58:48 ET Disc Medicine, Inc. (IRON) Stifel 2025 Healthcare Conference November 13, 2025 8:40 AM EST... Read the full article on Seeking Alpha For further details see: Disc Medicine, Inc. (IRON) Presents at Stifel 2025 Healthcare Conference Transcript